retatrutide clinical trials status 2025 Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁

GLP 1 Probiotic PRO Introduction GLP-1 Probiotic PRO is a premium probiotic supplement from Pendulum, designed to support appetite control and promote a healthy gut ecosystem

The Ominous Octet: Multiple Pathophysiologic Defects in Type 2 Diabetes Mellitus (T2DM) 2 This review will focus on incretin-based therapies (DPP-4 inhibitors and GLP-1 receptor agonists) and SGLT-2 inhibitors currently approved for the treatment of T2DM

Research has shown reduced melanin levels compared to placebo groups, though results vary based on metabolism, dosage, and absorption

2025: Biocon strengthened its GLP-1 presence with two key milestones